Factors Influencing Patient Confidence in Screening Mammography

References

1. 1.↵
   1. DeSantis CE,
   2. Ma J,
   3. Gaudet MM,
   4. et al

   . Breast cancer statistics, 2019. CA Cancer J Clin 2019;69:438–51.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Joe BN,
   2. Sickles EA

   . The evolution of breast imaging: past to present. Radiology 2014;273:S23–44.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Gotzsche PC,
   2. Olsen O

   . Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129–34.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Patel NS,
   2. Lee M,
   3. Marti JL

   . Assessment of screening mammography recommendations by breast cancer centers in the US. JAMA Intern Med 2021;181:717–9.

   OpenUrl
5. 5.↵
   US Preventive Services Task Force. Breast cancer: screening. Accessed 2023 Feb 7. Available at: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening.
6. 6.↵
   1. Bredemeyer M

   . ACS releases guideline on breast cancer screening. Am Fam Physician. 2016;93:711–2.

   OpenUrl
7. 7.↵
   National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): breast cancer screening and diagnosis. Accessed Feb 7 2023, Version 1.2022. Available at: https://www.nccn.org/.
8. 8.↵
   1. Woloshin S,
   2. Schwartz LM,
   3. Byram SJ,
   4. Sox HC,
   5. Fischhoff B,
   6. Welch HG

   . Women's understanding of the mammography screening debate. Arch Intern Med 2000;160:1434–40.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Schueler KM,
   2. Chu PW,
   3. Smith-Bindman R

   . Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt) 2008;17:1477–98.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Chamot E,
    2. Perneger TV

    . Misconceptions about efficacy of mammography screening: a public health dilemma. J Epidemiol Community Health 2001;55:799–803.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Kerlikowske K,
    2. Hubbard RA,
    3. Miglioretti DL

    , Breast Cancer Surveillance Consortiumet al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med 2011;155:493–502.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Pisano ED,
    2. Gatsonis C,
    3. Hendrick E

    , Digital Mammographic Imaging Screening Trial (DMIST) Investigators Groupet al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005;353:1773–83.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Lehman CD,
    2. Arao RF,
    3. Sprague BL,
    4. et al

    . National performance benchmarks for modern screening digital mammography: update from the Breast Cancer Surveillance Consortium. Radiology 2017;283:49–58.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Freer PE

    . Mammographic breast density: impact on breast cancer risk and implications for screening. Radiographics 2015;35:302–15.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Boyd NF,
    2. Guo H,
    3. Martin LJ,
    4. et al

    . Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227–36.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Boyd NF,
    2. Martin LJ,
    3. Yaffe MJ,
    4. Minkin S

    . Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 2011;13:223.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Carney PA,
    2. Miglioretti DL,
    3. Yankaskas BC,
    4. et al

    . Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168–75.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Duffy S,
    2. Vulkan D,
    3. Cuckle H,
    4. et al

    . Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Health Technol Assess 2020;24:1–24.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Tosteson ANA,
    2. Schifferdecker KE,
    3. Smith RE,
    4. et al

    . Women's breast cancer screening confidence by screening modality and breast density: a Breast Cancer Surveillance Consortium Survey Study. J Womens Health (Larchmt) 2022;31:1547–56.

    OpenUrl
20. 20.↵
    1. Horsley RK,
    2. Kling JM,
    3. Vegunta S,
    4. Lorans R,
    5. Temkit H,
    6. Patel BK

    . Baseline mammography: what is it and why is it important? a cross-sectional survey of women undergoing screening mammography. J Am Coll Radiol 2019;16:164–9.

    OpenUrl
21. 21.↵
    1. Harris PA,
    2. Taylor R,
    3. Minor BL

    , REDCap Consortiumet al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019;95:103208.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Harris PA,
    2. Taylor R,
    3. Thielke R,
    4. Payne J,
    5. Gonzalez N,
    6. Conde JG

    . Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81. Apr.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Damiani G,
    2. Basso D,
    3. Acampora A,
    4. et al

    . The impact of level of education on adherence to breast and cervical cancer screening: evidence from a systematic review and meta-analysis. Prev Med 2015;81:281–9.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Duport N,
    2. Ancelle-Park R

    . Do socio-demographic factors influence mammography use of French women? Analysis of a French cross-sectional survey. Eur J Cancer Prev 2006;15:219–24.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Lee JR,
    2. Vogel VG

    . Who uses screening mammography regularly? Cancer Epidemiol Biomarkers Prev 1995;4:901–6.

    OpenUrlAbstract
26. 26.↵
    1. Dobias KS,
    2. Moyer CA,
    3. McAchran SE,
    4. Katz SJ,
    5. Sonnad SS

    . Mammography messages in popular media: implications for patient expectations and shared clinical decision-making. Health Expect 2001;4:127–35.

    OpenUrlPubMed
27. 27.↵
    1. Rhodes DJ,
    2. Jenkins SM,
    3. Hruska CB,
    4. Vachon CM,
    5. Breitkopf CR

    . Breast density awareness, knowledge, and attitudes among US women: national survey results across 5 years. J Am Coll Radiol 2020;17:391–404.

    OpenUrl
28. 28.↵
    1. Santiago-Rivas M,
    2. Benjamin S,
    3. Andrews JZ,
    4. Jandorf L

    . Breast density awareness and knowledge, and intentions for breast cancer screening in a diverse sample of women age eligible for mammography. J Cancer Educ 2019;34:90–7.

    OpenUrlPubMed
29. 29.↵
    1. Kerlikowske K,
    2. Zhu W,
    3. Hubbard RA

    , Breast Cancer Surveillance Consortiumet al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med 2013;173:807–16.

    OpenUrl
30. 30.↵
    1. Schifferdecker KE,
    2. Tosteson ANA,
    3. Kaplan C,
    4. et al

    . Knowledge and perception of breast density, screening mammography, and supplemental screening: in search of “informed”. J Gen Intern Med 2020;35:1654–60.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. de Lange SV,
    2. Bakker MF,
    3. Monninkhof EM,
    4. et al

    . Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts. Clin Radiol 2018;73:759 e1-759–e9.

    OpenUrl
32. 32.↵
    1. Costanza ME,
    2. Stoddard A,
    3. Gaw VP,
    4. Zapka JG

    . The risk factors of age and family history and their relationship to screening mammography utilization. J Am Geriatr Soc 1992;40:774–8.

    OpenUrlPubMedWeb of Science
33. 33.↵
    1. Chagpar AB,
    2. Polk HC Jr.,
    3. McMasters KM

    . Racial trends in mammography rates: a population-based study. Surgery 2008;144:467–72.

    OpenUrlCrossRefPubMedWeb of Science